| 臺大學術典藏 |
2020-07-21T06:46:19Z |
Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum
|
Liao W.-Y.; CHAO-CHI HO; Tsai T.-H.; Chen K.-Y.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:46:19Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Yu C.-J.; CHAO-CHI HO; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.; Lin C.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:46:18Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Ko J.-C.; Shih J.-Y.; Liang S.-K.; Lee M.-R.; Liao W.-Y.; CHAO-CHI HO |
| 臺大學術典藏 |
2020-07-21T06:46:18Z |
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non–Small-cell Lung Cancer Patients
|
Wu T.-H.; Hsiue E.H.-C.; Lee J.-H.; Lin C.-C.; Liao W.-Y.; CHAO-CHI HO; Shih J.-Y.; Yu C.-J.; Yang J.C.-H. |
| 臺大學術典藏 |
2020-07-21T06:46:17Z |
The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancer
|
Hsu C.-L.; Lin C.-K.; Liao W.-Y.; Yu K.-L.; Tsai T.-H.; CHAO-CHI HO; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:46:16Z |
Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients
|
Yao Z.-H.; Liao W.-Y.; CHAO-CHI HO; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:46:16Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Lin Y.-T.; Chen J.-S.; Liao W.-Y.; CHAO-CHI HO; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:46:15Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Chang Y.-L.; Su K.-Y.; Hsu C.-L.; Liu Y.-N.; Chen K.-Y.; Tsai T.-H.; Liao W.-Y.; CHAO-CHI HO; Yang C.-Y. |
| 臺大學術典藏 |
2020-07-21T06:25:18Z |
Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy
|
Yang P.-C.; Shih J.-Y.; Yang J.C.H.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Jan I.-S.; Chen K.-Y.; Wang J.-Y.; Ruan S.-Y.; Yang C.-Y.; TZU-HSIU TSAI |
| 臺大學術典藏 |
2020-07-21T06:25:17Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Yang J.C.-H.; Thress K.S.; Huang D.D.-R.; Lin C.-C.;Shih J.-Y.;Yu C.-J.;Ho C.-C.;Liao W.-Y.;Lee J.-H.;Tzu-Hsiu Tsai;Su K.-Y.;Hsieh M.-S.;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Lee J.-H.; TZU-HSIU TSAI; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y. |
| 臺大學術典藏 |
2020-07-21T06:25:17Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Liao W.-Y.; Ho C.-C.; Liao B.-C.; Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Liao W.-Y.;Chen K.-Y.;Tzu-Hsiu Tsai;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Yang J.C.; Yu C.-J.; Shih J.-Y.; Lin C.-C.; Lee J.-H.; Chang Y.-L.; Su K.-Y.; Hsu W.-H.; Hsu C.-L.; TZU-HSIU TSAI; Chen K.-Y. |
| 臺大學術典藏 |
2020-07-21T06:25:16Z |
The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancer
|
Yu K.-L.;Tzu-Hsiu Tsai;Ho C.-C.;Liao W.-Y.;Lin C.-K.;Hsu C.-L.;Shih J.-Y.; Yu K.-L.; TZU-HSIU TSAI; Ho C.-C.; Liao W.-Y.; Lin C.-K.; Hsu C.-L.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:25:16Z |
Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum
|
Liao W.-Y.;Ho C.-C.;Tzu-Hsiu Tsai;Chen K.-Y.;Shih J.-Y.;Yu C.-J.; Liao W.-Y.; Ho C.-C.; TZU-HSIU TSAI; Chen K.-Y.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:25:15Z |
Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors
|
Shih J.-Y.; Liao W.-Y.; Lee J.-H.;Chen H.-Y.;Hsu F.-M.;Chen J.-S.;Liao W.-Y.;Shih J.-Y.;Yu C.-J.;Chen K.-Y.;Tzu-Hsiu Tsai;Yang J.C.-H.; Lee J.-H.; Chen H.-Y.; Hsu F.-M.; Chen J.-S.; Yang J.C.-H.; Yu C.-J.; Chen K.-Y.; TZU-HSIU TSAI |
| 臺大學術典藏 |
2020-07-21T05:40:29Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Lee J.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Ching-Yao Yang;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; CHING-YAO YANG; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H. |
| 臺大學術典藏 |
2020-06-30T08:10:05Z |
Identification of Five Driver Gene Mutations in Patients with Treatment-Na?ve Lung Adenocarcinoma in Taiwan
|
Hsu K.-H.;Ho C.-C.;Hsia T.-C.;Tseng J.-S.;Kang-Yi Su;Wu M.-F.;Chiu K.-L.;Yang T.-Y.;Chen K.-C.;Ooi H.;Wu T.-C.;Chen H.-J.;Chen H.-Y.;Chang C.-S.;Hsu C.-P.;Hsia J.-Y.;Chuang C.-Y.;Lin C.-H.;Chen J.J.W.;Chen K.-Y.;Liao W.-Y.;Shih J.-Y.;Yu S.-L.;Yu C.-J.;Yang P.-C.;Chang G.-C.; Hsu K.-H.; Ho C.-C.; Hsia T.-C.; Tseng J.-S.; KANG-YI SU; Wu M.-F.; Chiu K.-L.; Yang T.-Y.; Chen K.-C.; Ooi H.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; Chen K.-Y.; Liao W.-Y.; Shih J.-Y.; Yu S.-L.; Yu C.-J.; Yang P.-C.; Chang G.-C. |
| 臺大學術典藏 |
2020-06-30T08:10:03Z |
EGFR mutation and lobar location of lung adenocarcinoma
|
Tseng C.-H.;Chen K.-C.;Hsu K.-H.;Tseng J.-S.;Ho C.-C.;Hsia T.-C.;Kang-Yi Su;Wu M.-F.;Chiu K.-L.;Liu C.-M.;Wu T.-C.;Chen H.-J.;Chen H.-Y.;Chang C.-S.;Hsu C.-P.;Hsia J.-Y.;Chuang C.-Y.;Lin C.-H.;Chen J.J.W.;Chen K.-Y.;Liao W.-Y.;Shih J.-Y.;Yu S.-L.;Yu C.-J.;Yang P.-C.;Yang T.-Y.;Chang G.-C.; Tseng C.-H.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Ho C.-C.; Hsia T.-C.; KANG-YI SU; Wu M.-F.; Chiu K.-L.; Liu C.-M.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; Chen K.-Y.; Liao W.-Y.; Shih J.-Y.; Yu S.-L.; Yu C.-J.; Yang P.-C.; Yang T.-Y.; Chang G.-C. |
| 臺大學術典藏 |
2020-06-30T08:09:57Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Liao W.-Y.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Kang-Yi Su;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; KANG-YI SU; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2020-06-30T08:09:56Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Lin C.-C.;Shih J.-Y.;Yu C.-J.;Ho C.-C.;Liao W.-Y.;Lee J.-H.;Tsai T.-H.;Kang-Yi Su;Hsieh M.-S.;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; KANG-YI SU; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H. |
| 臺大學術典藏 |
2020-06-30T08:09:52Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Kang-Yi Su;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; KANG-YI SU; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-06-30T08:09:51Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Kang-Yi Su;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; KANG-YI SU; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-06-16T06:32:18Z |
Rapid atmospheric-pressure-plasma-jet processed porous materials for energy harvesting and storage devices
|
Chen, J.-Z.;Hsu, C.-C.;Wang, C.;Liao, W.-Y.;Wu, C.-H.;Wu, T.-J.;Liu, H.-W.;Chang, H.;Lien, S.-T.;Li, H.-C.;Hsu, C.-M.;Kao, P.-K.;Yang, Y.-J.;Cheng, I.-C.; Chen, J.-Z.; Hsu, C.-C.; Wang, C.; Liao, W.-Y.; Wu, C.-H.; Wu, T.-J.; Liu, H.-W.; Chang, H.; Lien, S.-T.; Li, H.-C.; Hsu, C.-M.; Kao, P.-K.; Yang, Y.-J.; Cheng, I.-C.; I-CHUN CHENG |
| 臺大學術典藏 |
2020-06-16T06:32:11Z |
Atmospheric-pressure-plasma-jet sintered dual-scale porous TiO2 using an economically favorable NaCl solution
|
Liao, W.-Y.;Yang, Y.-J.;Hsu, C.-M.;Hsu, C.-C.;Cheng, I.-C.;Chen, J.-Z.; Liao, W.-Y.; Yang, Y.-J.; Hsu, C.-M.; Hsu, C.-C.; Cheng, I.-C.; Chen, J.-Z.; I-CHUN CHENG |
| 臺大學術典藏 |
2020-06-16T06:32:08Z |
Oxygen-deficient indium tin oxide thin films annealed by atmospheric pressure plasma jets with/without air-quenching
|
Liao, W.-Y.;Chang, H.;Yang, Y.-J.;Hsu, C.-C.;Cheng, I.-C.;Chen, J.-Z.; Liao, W.-Y.; Chang, H.; Yang, Y.-J.; Hsu, C.-C.; Cheng, I.-C.; Chen, J.-Z.; I-CHUN CHENG |
| 臺大學術典藏 |
2020-05-26T09:27:09Z |
Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum
|
Yu C.-J.;Chen Y.-M;Chih-Hsin Yang;Cheng Y.-K;Chang G.-C;Shih J.-Y;Liao W.-Y; Liao W.-Y; Shih J.-Y; Chang G.-C; Cheng Y.-K; CHIH-HSIN YANG; Chen Y.-M; Yu C.-J. |
